LNTH — Lantheus Holdings, Inc. stock price, charts and financials

QT74Lantheus Holdings, Inc.

Lantheus Holdings, Inc. (NASDAQ: LNTH) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
101.11
-0.08-0.08%
OverviewShort InterestFilings
LNTHQT74Lantheus Holdings, Inc.·NASDAQ
101.11-0.08%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 2026DEFA14AAdditional proxy soliciting materials
Aug 04, 20268-KCurrent report
Aug 04, 2026DEFA14AAdditional proxy soliciting materials
Aug 03, 2026DEFA14AAdditional proxy soliciting materials
Aug 03, 20268-KCurrent report
Aug 03, 2026DEFA14AAdditional proxy soliciting materials
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
May 29, 2026SDSpecialized disclosure report
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
May 01, 20268-KCurrent report
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 21, 20264Statement of changes in beneficial ownership
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 20, 2026DEFA14AAdditional proxy soliciting materials
#1 / 25 of 420
Page
▼
/ 17